RETACRIT is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Vifor (international) Inc.. The primary component is Erythropoietin.
Product ID | 59353-004_3adf0922-a716-4bad-88b6-983a2e259a44 |
NDC | 59353-004 |
Product Type | Human Prescription Drug |
Proprietary Name | RETACRIT |
Generic Name | Epoetin Alfa-epbx |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2018-06-18 |
Marketing Category | BLA / BLA |
Application Number | BLA125545 |
Labeler Name | Vifor (International) Inc. |
Substance Name | ERYTHROPOIETIN |
Active Ingredient Strength | 4000 [iU]/mL |
Pharm Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [CS],Increased Erythroid Cell Production [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-06-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125545 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-06-18 |
Marketing Category | BLA |
Application Number | BLA125545 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-06-18 |
Ingredient | Strength |
---|---|
ERYTHROPOIETIN | 4000 [iU]/mL |
SPL SET ID: | e6e4dd0c-25ca-40b2-ba6b-6138a68621fe |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0069-1305 | RETACRIT | epoetin alfa-epbx |
0069-1306 | RETACRIT | epoetin alfa-epbx |
0069-1307 | RETACRIT | epoetin alfa-epbx |
0069-1308 | RETACRIT | epoetin alfa-epbx |
0069-1309 | RETACRIT | epoetin alfa-epbx |
0069-1311 | RETACRIT | epoetin alfa-epbx |
0069-1318 | RETACRIT | epoetin alfa-epbx |
59353-004 | RETACRIT | RETACRIT |
59353-002 | RETACRIT | RETACRIT |
59353-003 | RETACRIT | RETACRIT |
59353-010 | RETACRIT | RETACRIT |
59353-120 | RETACRIT | RETACRIT |
59353-220 | RETACRIT | RETACRIT |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RETACRIT 87340145 5770173 Live/Registered |
Hospira, Inc. 2017-02-17 |
RETACRIT 85028565 3925022 Dead/Cancelled |
Hospira, Inc. 2010-05-03 |
RETACRIT 77117569 not registered Dead/Abandoned |
Hospira, Inc. 2007-02-27 |